TSH Biopharm Corporation Limited Board of Directors resolved to appoint the CFO of the Company. Name, title, and resume of the new position holder:Jung-Liang Kao, Senior Division Director of the Company;Chief Audit Executive of TTY Biopharm Company Limited;Auditor General,CFO, and acting spokesperson of 104 CORPORATION;Senior Director of Audit Department of PwC Taiwan. The newly appointed CFO will take office on April 1, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
58.6 TWD | -2.82% | +3.35% | +16.50% |
Mar. 11 | TSH Biopharm Corporation Limited Announces Directorate Changes on April 1, 2024 | CI |
Mar. 11 | TSH Biopharm Corporation Limited Appoints Jung-Liang Kao as CFO on April 1, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+16.50% | 69.11M | |
+30.36% | 699B | |
+25.07% | 571B | |
-4.50% | 364B | |
+18.24% | 326B | |
+3.63% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.56% | 154B |
- Stock Market
- Equities
- 8432 Stock
- News TSH Biopharm Corporation Limited
- TSH Biopharm Corporation Limited Appoints Jung-Liang Kao as CFO on April 1, 2024